Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Pharmacogenomics ; 15(1): 29-37, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24329188

ABSTRACT

BACKGROUND: In recent years, pharmacogenetic algorithms were developed for estimating the appropriate dose of vitamin K antagonists. AIM: To evaluate the performance of new generation artificial neural networks (ANNs) to predict the warfarin maintenance dose. METHODS: Demographic, clinical and genetic data (CYP2C9 and VKORC1 polymorphisms) from 377 patients treated with warfarin were used. The final prediction model was based on 23 variables selected by TWIST® system within a bipartite division of the data set (training and testing) protocol. RESULTS: The ANN algorithm reached high accuracy, with an average absolute error of 5.7 mg of the warfarin maintenance dose. In the subset of patients requiring ≤21 mg and 21-49 mg (45 and 51% of the cohort, respectively) the absolute error was 3.86 mg and 5.45 with a high percentage of subjects being correctly identified (71 and 73%, respectively). CONCLUSION: ANN appears to be a promising tool for vitamin K antagonist maintenance dose prediction.


Subject(s)
Anticoagulants/administration & dosage , Drug Dosage Calculations , Vitamin K/antagonists & inhibitors , Warfarin/administration & dosage , Aged , Aged, 80 and over , Aryl Hydrocarbon Hydroxylases/genetics , Cytochrome P-450 CYP2C9 , Dose-Response Relationship, Drug , Female , Humans , International Normalized Ratio , Male , Neural Networks, Computer , Polymorphism, Genetic , Vitamin K/administration & dosage , Vitamin K Epoxide Reductases/genetics
2.
Dig Liver Dis ; 44(6): 461-5, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22285147

ABSTRACT

BACKGROUND: Specific bacterial infections or alterations of the gut microbiota likely trigger immuno-pathological phenomena associated with Crohn's disease and ulcerative colitis. Mycobacterium avium subspecies paratuberculosis is a candidate etiological agent of Crohn's disease. Definitive causal connection between Mycobacterium avium subspecies paratuberculosis infection and Crohn's disease has not been demonstrated. AIMS: To determine the circulation of Mycobacterium avium subspecies paratuberculosis in Crohn's disease patients and water supplies in an Italian region where this bacterium is endemic in cattle farms. METHODS: Mycobacterium avium subspecies paratuberculosis screening was performed on biopsies from human patients, and from water samples, using two different PCR procedures. RESULTS: In hospitals where multiple specimens were obtained from different sites in the intestine, the prevalence of Mycobacterium avium subspecies paratuberculosis infection was 82.1% and 40% respectively in Crohn's disease and ulcerative colitis patients; in another hospital, where single specimens were obtained from patients, the bacterium was not detected. Control subjects also harboured Mycobacterium avium subspecies paratuberculosis, but at a lower prevalence. Tap water samples collected in the study area contained Mycobacterium avium subspecies paratuberculosis DNA. DISCUSSION: The results of screenings for Mycobacterium avium subspecies paratuberculosis in humans are deeply influenced by both the number and location of the collected biopsies. There is a wide circulation of the organism in the study area, considering the prevalence in humans and its presence in drinking water.


Subject(s)
Crohn Disease/microbiology , DNA, Bacterial/isolation & purification , Drinking Water/microbiology , Mycobacterium avium subsp. paratuberculosis/isolation & purification , Paratuberculosis/epidemiology , Chi-Square Distribution , Colitis, Ulcerative/microbiology , Humans , Intestines/microbiology , Italy/epidemiology , Paratuberculosis/complications , Prevalence
3.
Oncol Rep ; 19(6): 1605-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18497972

ABSTRACT

Telomeres, the ends of eukaryotic chromosomes, have a variable length among individuals and cell types. While studies in telomerase-deficient mice and cells showed an inverse correlation between telomere length and radiosensitivity, it is less clear whether this remains true in telomerase-proficient cells. To gain insight into this topic, we studied radiosensitivity in three telomerase immortalized fibroblast clones derived from the same cell line and characterized by different telomere length. In two clones, cen3tel4 and cen3tel5, the mean terminal restriction fragment length was approximately 13 and 10 kb, respectively and in the third clone, cen3pci16, it was approximately 4 kb, which is lower than in senescent fibroblasts. To test radiosensitivity, we determined survival to gamma-rays and the induction of chromosomal aberrations after irradiation. Neither the LD50, the gamma-ray dose that reduces survival to 50%, nor the frequency of aberrations detected in the three cell lines showed an inverse correlation with telomere length. In particular, the cen3pci16 cells, which have very short telomeres, did not show a higher sensitivity to irradiation or a greater frequency of chromosomal abnormalities compared to the other two cell lines. Our results suggest that, in the presence of telomerase activity, short telomeres are stabilized and do not cause an increase in radiosensitivity.


Subject(s)
Fibroblasts/pathology , Fibroblasts/radiation effects , Gamma Rays , Radiation Tolerance , Telomerase/metabolism , Telomere/physiology , Cells, Cultured , Chromosome Aberrations , Cobalt Radioisotopes , Dose-Response Relationship, Radiation , Fibroblasts/enzymology , Humans , Telomerase/genetics , Telomere/radiation effects
4.
Antimicrob Agents Chemother ; 51(6): 2028-34, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17438061

ABSTRACT

Herpes B virus (B virus [BV]) is a macaque herpesvirus that is occasionally transmitted to humans where it can cause rapidly ascending encephalitis that is often fatal. To understand the low susceptibility of BV to the acyclonucleosides, we have cloned, expressed, and characterized the BV thymidine kinase (TK), an enzyme that is expected to "activate" nucleoside analogs. This enzyme is similar in sequence and properties to the TK of herpes simplex virus (HSV), i.e., it has a broad substrate range and low enantioselectivity and is sensitive to inhibitors of HSV TKs. The BV enzyme phosphorylates some modified nucleosides and acyclonucleosides and l enantiomers of thymidine and related antiherpetic analogs. However, the potent anti-HSV drugs acyclovir (ACV), ganciclovir (GCV), and 5-bromovinyldeoxyuridine were poorly or not phosphorylated by the BV enzyme under the experimental conditions. The antiviral activities of a number of marketed antiherpes drugs and experimental compounds were compared against BV strains and, for comparison, HSV type 1 (HSV-1) in Vero cell cultures. For most compounds tested, BV was found to be about as sensitive as HSV-1 was. However, BV was less sensitive to ACV and GCV than HSV-1 was. The abilities of thymidine analogs and acyclonucleosides to inhibit replication of BV in Vero cell culture were not always proportional to their substrate properties for BV TK. Our studies characterize BV TK for the first time and suggest new lead compounds, e.g., 5-ethyldeoxyuridine and pencyclovir, which may be superior to ACV or GCV as treatment for this emerging infectious disease.


Subject(s)
Antiviral Agents , Herpesvirus 1, Cercopithecine/drug effects , Nucleosides , Thymidine Kinase/metabolism , Acyclovir/analogs & derivatives , Acyclovir/chemistry , Acyclovir/pharmacology , Amino Acid Sequence , Animals , Antiviral Agents/chemistry , Antiviral Agents/metabolism , Antiviral Agents/pharmacology , Chlorocebus aethiops , Deoxyuridine/analogs & derivatives , Deoxyuridine/chemistry , Deoxyuridine/pharmacology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/metabolism , Guanine , Herpesvirus 1, Cercopithecine/enzymology , Herpesvirus 1, Cercopithecine/genetics , Microbial Sensitivity Tests/methods , Molecular Sequence Data , Nucleosides/chemistry , Nucleosides/metabolism , Nucleosides/pharmacology , Phosphorylation , Substrate Specificity , Thymidine/analogs & derivatives , Thymidine/metabolism , Thymidine Kinase/antagonists & inhibitors , Thymidine Kinase/chemistry , Thymidine Kinase/genetics , Vero Cells
6.
J Med Chem ; 48(11): 3919-29, 2005 Jun 02.
Article in English | MEDLINE | ID: mdl-15916444

ABSTRACT

Derivatives of the herpes simplex thymidine kinase inhibitor HBPG [2-phenylamino-9-(4-hydroxybutyl)-6-oxopurine] have been synthesized and tested for inhibitory activity against recombinant enzymes (TK) from herpes simplex types 1 and 2 (HSV-1, HSV-2). The compounds inhibited phosphorylation of [3H]thymidine by both enzymes, but potencies differed quantitatively from those of HBPG and were generally greater for HSV-2 than HSV-1 TKs. Changes in inhibitory potency were generally consistent with the inhibitor/substrate binding site structure based on published X-ray structures of HSV-1 TK. In particular, several 9-(4-aminobutyl) analogues with bulky tertiary amino substituents were among the most potent inhibitors. Variable substrate assays showed that the most potent compound, 2-phenylamino-9-[4-(1-decahydroquinolyl)butyl]-6-oxopurine, was a competitive inhibitor, with Ki values of 0.03 and 0.005 microM against HSV-1 and HSV-2 TKs, respectively. The parent compound HBPG was uniquely active in viral infection models in mice, both against ocular HSV-2 reactivation and against HSV-1 and HSV-2 encephalitis. In assays lacking [3H]thymidine, HBPG was found to be an efficient substrate for the enzymes. The ability of the TKs to phosphorylate HBPG may relate to its antiherpetic activity in vivo.


Subject(s)
Antiviral Agents/chemical synthesis , Guanine/analogs & derivatives , Guanine/chemical synthesis , Herpesvirus 1, Human/enzymology , Herpesvirus 2, Human/enzymology , Purinones/chemical synthesis , Thymidine Kinase/antagonists & inhibitors , Animals , Antiviral Agents/metabolism , Antiviral Agents/pharmacology , Cloning, Molecular , Encephalitis, Herpes Simplex/drug therapy , Encephalitis, Herpes Simplex/virology , Eye Infections, Viral/drug therapy , Eye Infections, Viral/virology , Guanine/chemistry , Guanine/pharmacology , Herpesvirus 1, Human/drug effects , Herpesvirus 2, Human/drug effects , Mice , Phosphorylation , Purinones/metabolism , Purinones/pharmacology , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/biosynthesis , Recombinant Proteins/isolation & purification , Structure-Activity Relationship , Thymidine Kinase/biosynthesis , Thymidine Kinase/isolation & purification , Virus Activation/drug effects
7.
Biochem Pharmacol ; 68(4): 711-8, 2004 Aug 15.
Article in English | MEDLINE | ID: mdl-15276078

ABSTRACT

In this paper, the enantioselectivity of ribonucleotide reductase (RNR, EC 1.17.4.1), a pivotal enzyme involved in DNA biosynthesis, was studied using the beta-d and beta-l stereoisomers of 2'-azido-2'-deoxynucleosides of uracil and cytosine. The corresponding 5'-diphosphate derivatives in the d-configuration have been extensively studied as mechanism-based inhibitors of the enzyme. The original l-enantiomers were synthesized and evaluated in vitro. In cell culture experiments, only the cytosine derivative with a d-configuration was found cytostatic and able to deplete dNTP pools in response to RNR inhibition. In the case of the uracil enantiomeric pair, this result correlates with an inefficient intracellular monophosphorylation as demonstrated in testing their substrate properties against human uridine-cytidine kinase 1. Regarding cytosine analogues, human deoxycytidine kinase was found to be able to phosphorylate both enantiomers with comparable efficiency but only the d-stereoisomer was active in human cell culture. The interaction of the beta-d and beta-l stereoisomers of 2'-azido-2'-deoxyuridine 5'-diphosphate with purified Escherichia coli RNR was also examined. Inactivation of the enzyme was only observed in the presence of the d-stereoisomer, demonstrating that RNR exhibits enantiospecificity with respect to the natural configuration of the sugar moiety, as far as 2'-azido-2'-deoxynucleotides are concerned.


Subject(s)
Antineoplastic Agents/pharmacology , Cytidine/analogs & derivatives , Deoxyribonucleosides/pharmacology , Deoxyuridine/analogs & derivatives , Ribonucleotide Reductases/antagonists & inhibitors , Antineoplastic Agents/chemistry , Azides/chemistry , Azides/pharmacology , Carbohydrates/chemistry , Cell Division/drug effects , Cloning, Molecular , Cytidine/chemistry , Cytidine/pharmacology , Deoxycytidine Kinase/genetics , Deoxycytidine Kinase/metabolism , Deoxyribonucleosides/chemistry , Deoxyuridine/chemistry , Deoxyuridine/pharmacology , Humans , Phosphorylation , Stereoisomerism , Structure-Activity Relationship , Tumor Cells, Cultured , Uridine Kinase/genetics , Uridine Kinase/metabolism
8.
Antivir Chem Chemother ; 14(4): 183-94, 2003 Jul.
Article in English | MEDLINE | ID: mdl-14582847

ABSTRACT

Continuing our investigations on inhibitors of ribonucleotide reductase (RNR), the crucial enzyme that catalyses the reduction of ribonucleotides to deoxyribonucleotides, we have now prepared and evaluated 5'-phosphonoacetic acid, amide and ester analogues of adenosine, uridine and cytidine with the aim to verify both substrate specificity and contribution to biological activity of diphosphate mimic moieties. A molecular modelling study has been conducted on the RNR R1 subunit, in order to verify the possible interaction of the proposed bioisosteric moieties. The study compounds were finally tested on the recombinant murine RNR showing a degree of inhibition that ranged from 350 microM for the UDP analogue 5'-deoxy-5'-N-(phosphon-acetyl)uridine sodium salt (amide) to 600 microM for the CDP analogue 5'-O-[(diethyl-phosphon)acetyl]cytidine (ester). None of the tested compounds displayed noteworthy cytostatic activity at 100-500 microM concentrations, whereas ADP analogue 5'-N-[(diethyl-phosphon) acetyl]adenosine (amide) and 5'-deoxy-5'-N-(phosphon-acetyl)adenosine sodium salt (amide) showed a moderate inhibitory activity (EC50: 48 microM) against HSV-2 and a modest inhibitory activity (EC50: 110 microM) against HIV-1, respectively.


Subject(s)
Antiviral Agents/pharmacology , Drug Design , Enzyme Inhibitors/chemical synthesis , Esters/chemistry , Phosphonoacetic Acid/analogs & derivatives , Phosphonoacetic Acid/pharmacology , Ribonucleotide Reductases/antagonists & inhibitors , Amides/chemistry , Animals , Antiviral Agents/chemical synthesis , Antiviral Agents/chemistry , Antiviral Agents/toxicity , Binding Sites/drug effects , Cell Line , Cell Line, Tumor , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , HIV-1/drug effects , HIV-1/physiology , Inhibitory Concentration 50 , Mice , Models, Molecular , Molecular Conformation , Molecular Structure , Nucleosides/chemistry , Phosphonoacetic Acid/chemistry , Ribonucleotide Reductases/metabolism
9.
Biochem Biophys Res Commun ; 308(4): 914-21, 2003 Sep 05.
Article in English | MEDLINE | ID: mdl-12927806

ABSTRACT

Several reports have shown that the ectopic expression of the human telomerase catalytic subunit gene (hTERT) leads to an indefinite extension of the life span of human fibroblasts cultured in vitro without the appearance of cancer-associated changes. We infected two fibroblast strains derived from centenarian individuals with an hTERT containing retrovirus and isolated transduced massive populations (cen2tel and cen3tel). In both populations, hTERT expression reconstituted telomerase activity and extended the life span. In cen2tel, a net telomere lengthening was observed while, in cen3tel, telomeres stabilized at a length lower than that detected in senescent parental cells. Interestingly, both cen2tel and cen3tel cells developed chromosome anomalies, numerical first and structural thereafter. Moreover, cen3tel cells acquired the ability to grow in the absence of solid support, a typical feature of transformed cells. The results we present here highlight an unexpected possible outcome of cellular immortalization driven by telomerase reactivation, and indicate that, in some cases, an artificial extension of cellular replicative capacity can increase the probability of occurrence of genomic alterations, which can lead to cellular transformation.


Subject(s)
Aging , Fibroblasts/metabolism , Telomerase/genetics , Telomerase/metabolism , Agar/metabolism , Aged , Aged, 80 and over , Cell Adhesion , Cell Division , Cell Transformation, Neoplastic , Cellular Senescence , Centromere/ultrastructure , Chromosome Aberrations , DNA/metabolism , DNA-Binding Proteins , Female , Humans , Karyotyping , Retroviridae/genetics , Telomere/ultrastructure , Time Factors
10.
Bioorg Med Chem ; 11(3): 357-66, 2003 Feb 06.
Article in English | MEDLINE | ID: mdl-12517431

ABSTRACT

Novel nucleoside analogues of both D and L enantiomeric series were prepared by coupling reaction between a 2',3'-dideoxy-3'-modified furanose moiety and four different nucleobases. Though in all cases anomeric mixtures of nucleosides were obtained, the presence of the sterically bulky 3'-tris(methylthio)methyl group allowed a good stereoselectivity level. All the compounds of both enantiomeric series showed high IC(50) values as HSV-1 TK inhibitors and scarce ability to be phosphorylated by HSV-1 TK. In order to overcome possible problems related to the first phosphorylation step and to facilitate the penetration of the molecule through the cellular membrane, a monophosphate prodrug containing a long lipophilic chain was synthesized. No appreciable antiviral activity was exhibited by this molecule.


Subject(s)
Furans/chemistry , Nucleosides/chemistry , Nucleosides/pharmacology , 3T3 Cells , Animals , Antiviral Agents/chemical synthesis , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Furans/chemical synthesis , Herpesvirus 1, Human/enzymology , Inhibitory Concentration 50 , Mice , Nucleosides/chemical synthesis , Phosphorylation , Stereoisomerism , Structure-Activity Relationship , Thymidine Kinase/antagonists & inhibitors , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...